Healthtech Startups

Hola Salud is a digital clinic in Mexico offering personalized weight-loss and metabolic treatments using GLP-1 medications (such as Mounjaro, Wegovy, and Ozempic) combined with care from certified physicians. It serves individuals and corporate clients, providing video consultations, dosage protocols, medication delivery, nutritional coaching, and 24/7 AI support.

1 investor

Salupay is a back-office software platform for managing insurance claims in healthcare facilities, automating the complete cycle from pre-acceptance through settlement. It consolidates fragmented processes across multiple portals into a single standardized interface with automatic verification, anomaly detection, and real-time tracking for Italian healthcare providers.

1 investor

Salusion provides software to set up and administer QSEHRA and ICHRA health reimbursement arrangements, handling compliance and automation for employers offering tax-free reimbursement of employees' health insurance and medical expenses. It serves companies looking to provide health benefits as an alternative or supplement to traditional group coverage.

1 investor

Salution Health is a human- and AI-powered health accelerator that helps healthcare organizations manage the full lifecycle of diagnostic and therapeutic products, including AI-enabled devices, software as a medical device, and cell and gene-based products. Its services span unmet needs identification, preclinical development, manufacturing, clinical trial design, regulatory strategy and submissions, quality systems, and post-market surveillance, supported by an agentic AI platform and a senior operating team.

1 investor

PT Samator Indo Gas is an industrial gas manufacturer producing chemicals such as nitrogen, oxygen, and carbon dioxide for industrial applications. The company is the largest national industrial gas company and is publicly listed on the Indonesian Stock Exchange.

1 investor

Sameday Health operates in-person clinics and virtual care offering primary care, lab testing, rapid STD/UTI/COVID testing, IV drip therapy, vitamin injections, addiction treatment, and vaccines. It serves individual patients in the United States, with a clinic in Costa Mesa, California.

1 investor

samedi provides cloud-based e-health software for medical practices, MVZs, and hospitals to manage online appointment scheduling, resource planning, digital patient forms, automated patient communication, video consultations, and white-label patient portals. The software integrates with existing practice management systems (PVS/KIS) and is offered primarily in Germany.

1 investor

Samepage builds an AI-powered information management platform for Product Managers that automatically surfaces insights and alignment data from scattered feedback, roadmaps, and research. The platform serves product teams at growing companies to eliminate information asymmetry and maintain alignment as organizations scale.

1 investor

SAMGI (Surgical Affiliates Management Group, Inc.) builds and manages acute care surgical teams for hospitals and health systems across the United States, supplying board-certified surgeons, providers, and medical directors for trauma, acute care, orthopedic, neurosurgery, urology, GI, vascular, and general surgery services. It also helps hospitals implement the emergency services and protocols needed to achieve ACS-Verified Trauma Center designation.

1 investor

Revv provides AI-enabled software that diagnoses advanced driver assistance systems (ADAS) for automotive repair shops, aiming to increase shop revenue and vehicle safety.

1 investor

SampleFacts develops microsampling devices for simplified blood cell and plasma collection, targeting researchers, clinical study professionals, and healthcare providers. The company builds on university research to enable easier, faster, and more reliable blood sampling for research, clinical studies, and diagnostics.

1 investor

Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.

1 investor

SanBio develops regenerative cell-based medicines for patients with neurological conditions, with its lead product SB623 used for chronic motor paralysis following traumatic brain injury. Its approved product is marketed in Japan as an intracerebral implant injection.

1 investor

Sandata provides an integrated platform that connects managed care organizations, homecare providers, and state agencies to improve communication and operational efficiency in home healthcare delivery. The company serves homecare agencies, intellectual/developmental disability service providers, managed care organizations, and state Medicaid programs.

1 investor

Sanfer is a pharmaceutical company that develops and markets prescription medicines, over-the-counter products, and animal health products across different therapeutic areas. It operates manufacturing facilities in Mexico and Latin America and provides medical content to prescribers through its Sanfer Conecta app.

1 investor

SaniSure develops Mixed4Sure, a single-use mixing platform for small-volume biopharmaceutical processing that handles volumes from 50 mL to 20 L with reduced shear forces and lower capital costs than traditional stainless-steel systems.

1 investor

1 investor

Sanius Health operates a platform and condition-specific apps that capture patient-reported symptoms, wellbeing and treatment experience alongside clinical data and continuous monitoring to build longitudinal real-world datasets. It serves patients, healthcare providers and research partners, supporting care between appointments and generating evidence for studies and treatment evaluation.

1 investor

Sanmai is developing a clinical ultrasound device that uses low-intensity transcranial ultrasound to deliver brain therapeutics. The company, structured as a public benefit corporation, is currently running trials and targets research clinics in the neurotherapeutics field.

1 investor

Sanmirna Therapeutics develops microRNA-targeted therapeutics for cancer treatment, with its lead candidate Miristen™ currently in Phase I clinical trials for acute myeloid leukemia. The company leverages microRNA discovery to create novel oncology treatments.

1 investor

Back in Action UK provides onsite occupational physiotherapy and workplace ergonomics services to corporate and public sector clients, focusing on rehabilitating employees with musculoskeletal issues and reducing work-related injuries and absence. Founded in 2001, it works with occupational health companies and physicians across the UK, delivering services directly at client sites.

1 investor

Sanolla develops AI-powered digital stethoscopes and wearable devices that analyze full-spectrum body sounds including infrasound for diagnostic and home monitoring applications. The company serves healthcare professionals and chronic disease patients in primary care, cardiology, and pulmonology with real-time diagnostic insights and early detection capabilities.

1 investor

Sanos provides clinical trial management services for pharmaceutical sponsors across multiple therapeutic areas, offering end-to-end capabilities from protocol development through regulatory approval. The company operates as a strategic partner for drug development, managing patient recruitment, data integrity, and operational execution with fixed budgets and timelines.

1 investor

SANSHO Co., Ltd. is a Japanese drug-development company creating pharmaceuticals based on cyclic phosphatidic acid (cPA), including 2-carba-cyclic phosphatidic acid candidates in clinical trials for knee osteoarthritis and pulmonary fibrosis. The company conducts research and development to bring these medicines to clinical use.

1 investor